New insider activity at Healthequity ( (HQY) ) has taken place on June 10, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Former Director Jon Kessler has made a significant move by selling 231,950 shares of Healthequity stock, amounting to a substantial $25,992,197.
Recent Updates on HQY stock
In the last 24 hours, HealthEquity’s stock has seen several price target increases from major firms, driven by strong financial performance and strategic initiatives. Barrington raised its price target due to HealthEquity’s Q1 results surpassing expectations and improved fiscal 2026 guidance, highlighting the company’s strong health savings account business and higher effective yield on cash. Deutsche Bank also increased its target, maintaining a Buy rating, while KeyBanc and RBC Capital cited robust Q1 results and effective fraud prevention measures as key factors. HealthEquity’s earnings call emphasized significant revenue growth, legislative developments potentially expanding the market for Health Savings Accounts, and record custodial revenue. Despite challenges like fraud costs and economic uncertainty, the company’s strategic focus on AI and legislative efforts are expected to sustain growth.
Spark’s Take on HQY Stock
According to Spark, TipRanks’ AI Analyst, HQY is a Outperform.
Healthequity’s strong financial performance and positive earnings call insights are the most significant strengths, showcasing robust growth and strategic initiatives. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates valuation concerns.
To see Spark’s full report on HQY stock, click here.
More about Healthequity
YTD Price Performance: 14.82%
Average Trading Volume: 1,246,530
Technical Sentiment Signal: Buy
Current Market Cap: $9.65B